“…4,6 Despite this, the US Food and Drug Administration has not approved metformin or any other pharmacologic agent to treat prediabetes. 4 Thus, prescribing metformin for prediabetes is technically considered off-label. However, the American Diabetes Association (ADA) denotes metformin therapy as a consideration for individuals with prediabetes, especially those with BMI ≥35 kg/m 2 , those age <60 years, and women with a history of gestational diabetes (Table 2).…”